| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0006 |
| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.002 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |